Cigna Group closed 20.66% short of its 52-week high of $370.83, which the company reached on September 16th.

Truist Financial analyst David S Macdonald reiterated a Buy rating on Cigna (CI – Research Report) today. The company’s shares closed yesterday ...

Cantor Fitzgerald analyst Sarah James maintained a Buy rating on Cigna (CI – Research Report) yesterday and set a price target of $350.00. The ...

Cigna Group inc. (NYSE: CI) shares are rebounding Friday after dropping on Thursday following a fourth-quarter earnings miss.

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

Shares of Cigna Group slipped 6.70% to $282.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.53% to 6,071.17 and the Dow ...

I've been a Cigna Global Health Insurance policyholder for seven years and had never filed a claim until recently. A few weeks ago, I had to undergo a surgical procedure. I first contacted Cigna ...

CEO David Cordani suggested Thursday that the moves are a direct response to the slaying of UnitedHealthcare CEO Brian Thompson and the public outcry over the state of health care. Other news is on ...

Wall Street was moving higher still shortly after the open, on the back of slightly better-than-expected readings for US ...